USA flag logo/image

An Official Website of the United States Government

Bipolar Coagulation of Occluding Tissue in VP Shunts

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
79663
Program Year/Program:
2006 / SBIR
Agency Tracking Number:
NS051924
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Infoscitex Corporation
303 Bear Hill Road Waltham, MA -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2006
Title: Bipolar Coagulation of Occluding Tissue in VP Shunts
Agency: HHS
Contract: 1R43NS051924-01A2
Award Amount: $137,879.00
 

Abstract:

DESCRIPTION (provided by applicant): Development of a bipolar coagulator is proposed for electrosurgical coagulation or cutting of adherent brain tissue that is occluding the flow of cerebrospinal fluid (CSF) into the intake holes of an implanted ventricular catheter. Currently, during revision surgery for ventriculoperitoneal (VP) shunts, monopolar coagulators are used to clear the occluding tissue, either to reestablish the function of the catheter or to allow it to be safely removed and replaced. For this application, however, bipolar coagulators offer better control of the distribution of the electrical current and may reduce the likelihood of serious complications. In particular, blood vessel damage and severe subarachnoid hemorrhages in some patients have been associated with the use of monopolar coagulation in VP shunt revision surgery. The proposed Phase I project will first establish a User Requirements Specification and then develop a set of prototypes for bipolar coagulators with electrode configurations suitable for operation inside a ventricular catheter. The prototypes will be integrated with available electro-surgical generators and inserted into ventricular catheters which have been immersed in fresh egg white. The testing will compare the bipolar prototypes with currently-used monopolar stylets with regard to the volume of coagulum produced, in order to accomplish a given coagulation task. As a last step, electrocautery will be applied to sheep brain tissue, obtained frozen from a suitable supplier, and analysis of the resulting lesion sizes will allow correction, if necessary, of the results obtained in egg white for brain tissue. Phase II is expected to verify the hypothesized benefits of bipolar coagulation in this application with animal models. Ventriculoperitoneal shunts are a life-saving treatment for hydrocephalus patients, but shunt catheters commonly become blocked over time and must be replaced to resolve this life-threatening situation. Neurosurgeons routinely employ off-label use of monopolar cautery to reduce the known risk of intraventricular hemorrhage (IVH) during the roughly 23,000 ventricular catheter revisions performed each year in the United States. However, IVH remains a risk, and recent case studies suggest an emerging risk of aneurysm formation associated with monopolar cautery in this application. The proposed bipolar coagulator is intended as a safer means for removal of occluded ventricular catheters from hydrocephalus patients undergoing shunt revision surgery.

Principal Investigator:

James H. Goldie
7812594022
JGOLDIE@INFOSCITEX.COM

Business Contact:

William Thompson
7818901338
bthompson@infoscitex.com
Small Business Information at Submission:

INFOSCITEX CORPORATION
INFOSCITEX CORPORATION 303 BEAR HILL RD WALTHAM, MA 02451

EIN/Tax ID: 043537120
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No